Jane Street Group, LLC Synthetic Biologics, Inc. Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$1.9 - $2.9 $535,230 - $816,930	-281,700 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$2.3 - $4.3 $647,910 - $1.21 Million	281,700 New	281,700 $80,000
Q4 2018 Feb 15, 2019	SELL	$5.2 - $26.8 $97,006 - $499,954	-18,655 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$20.4 - $80.5 $380,562 - $1.5 Million	18,655 New	18,655 $49,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.